“Chimeric antigen receptor T‑cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges”, Вопр. онкол., vol. 67, no. 3, pp. 350–360, Jul. 2021, doi: 10.37469/0507-3758-2021-67-3-350-360.